According to the American Cancer Society, the risk of men developing some type of cancer in their lifetime is around 1 in 2 or 42%, and the risk in women is around 1 in 3 or 37%.1
Did you know?
November is Lung, Pancreatic, and Prostate Cancer Awareness month.
Lung cancer is the leading cancer killer in both men and women in the US.2
Pancreatic cancer has the highest mortality rate of all major cancers.3
Prostate cancer is the most common cancer in men other than skin cancer.4
Based on these statistics, it is likely you may know someone who has cancer, had cancer, or will be diagnosed with cancer at one point in their life. What if in the future, that someone were you or an employee who works for you? It’s important to prepare for unexpected expenses. Critical Illness insurance provides a lump-sum payment to the insured if they suffer a major illness, which includes cancer, heart attack, stroke, major organ transplant or end stage renal disease. Employers can provide coverage for their employees for as little as $4 - $10 per month5 to help them prepare for an unexpected illness.
Nationwide's critical illness benefit plan can be used to help with the cost of treatment or expenses incurred due to the illness such as medical equipment, major medical deductibles, baby-sitters or additional groceries needed for family members helping during the time of need.
Lung cancer is the leading cancer killer in both men and women in the U.S. In 1987, it surpassed breast cancer to become the leading cause of cancer deaths in women.1
- An estimated 158,040 Americans are expected to die from lung cancer in 2015, accounting for approximately 27 percent of all cancer deaths.2
- The number of deaths caused by lung cancer has increased approximately 3.5 percent between 1999 and 2012 from 152,156 to 157,499. The number of deaths among men has plateaued but the number is still rising among women. In 2012, there were 86,740 deaths due to lung cancer in men and 70,759 in women.1
- The age-adjusted death rate for lung cancer is higher for men (56.1 per 100,000 persons) than for women (36.4 per 100,000 persons). It also is higher for blacks (48.3 per 100,000 persons) compared to whites (45.6 per 100,000 persons). Black men have a far higher age-adjusted lung cancer death rate than white men, while black and white women have similar rates.1
Pancreatic cancer facts
- An estimated 53,070 Americans will be diagnosed with pancreatic cancer in the U.S., and over 41,780 will die from the disease.
- Pancreatic cancer is one of the few cancers for which survival has not improved substantially over nearly 40 years.
- Pancreatic cancer is the 3rd leading cause of cancer-related death in the United States.
- Pancreatic cancer has the highest mortality rate of all major cancers. 94% of pancreatic cancer patients will die within five years of diagnosis – only 8% will survive more than five years. 74% of patients die within the first year of diagnosis.
- The average life expectancy after diagnosis with metastatic disease is just three to six months.
- Few risk factors for developing pancreatic cancer are defined. Family history of the disease, smoking, age, and diabetes are risk factors.
- Pancreatic cancer may cause only vague symptoms that could indicate many different conditions within the abdomen or gastrointestinal tract. Symptoms include pain (usually abdominal or back pain), weight loss, jaundice (yellowing of the skin and eyes), loss of appetite, nausea, changes in stool, and diabetes.
- Treatment options for pancreatic cancer are limited. Surgical removal of the tumor is possible in less than 20% of patients diagnosed with pancreatic cancer. Chemotherapy or chemotherapy together with radiation is typically offered to patients whose tumors cannot be removed surgically.
- Pancreatic cancer is a leading cause of cancer death largely because there are no detection tools to diagnose the disease in its early stages when surgical removal of the tumor is still possible.
Prostate cancer is the second leading cause of cancer death in men in the United States. It is estimated that 26,120 deaths from this disease will occur this year. Although the number of deaths from prostate cancer continues to decline among all men, the death rate remains more than twice as high in black men than any other group. A man’s individual survival depends on the type of prostate cancer and the stage of the disease.
Prostate cancer is the most common cancer among men, except for skin cancer. This year, an estimated 180,890 men in the United States will be diagnosed with prostate cancer. For unknown reasons, the risk of prostate cancer is 70% higher in blacks than in non-Hispanic whites. Most prostate cancers (92%) are found when the disease is confined to the prostate and nearby organs. This is referred to as the local or regional stage.